Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

PhD Candidate

Molecular And Cell Biology · Russia · 2025-03-28

Processing Time
157 days
Decision Date
2025-03-28
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to identify the molecular mechanisms and signaling pathways that modulate cellular metabolism in cancer models. This research focuses on discovering and developing effective therapeutic strategies for metabolic diseases and cancer to reduce the burden on the U.S. healthcare system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses significant public health challenges and metabolic diseases that burden the U.S. healthcare system.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record, patents, and NIH funding demonstrate a strong track record of success in molecular biology.

3 Waiver Benefit Met

The strategic importance of cancer research and the petitioner's unique expertise make it beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the client's record of 4 peer-reviewed journal articles, 2 patents, and 36 citations. Evidence included significant research funding from the National Institutes of Health (NIH) and alignment with the U.S. government’s Critical and Emerging Technologies List. The case was supported by 4 expert recommendation letters and satisfied all three Dhanasar prongs.

Request for Evidence (RFE)

Successfully Addressed

USCIS issued an RFE regarding the petitioner's qualifications and the national importance of the work. The response included detailed documentation of research influence and funding, which successfully addressed the concerns.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the EndeavorWaiver Benefit

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Michigan 48 days 2025-05-28
The petitioner proposes to explore how metabolic interactions within the tumor microenvironment can unlock new, personalized treatment strategies for cancer. Her work involves applying high-resolution metabolomic profiling tools integrated with experimental validation to develop predictive and precisely tailored therapies. The endeavor aims to accelerate clinical translation and improve survival rates for challenging cancer types.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 318 days 2025-12-12
The petitioner proposes to use small molecules in proteomic and multi-omic techniques to advance the understanding of cancer-relevant molecular pathways. This work focuses on identifying and characterizing mechanisms central to disease progression to support basic cancer research and treatment development.
View Case

Scientist

Biotechnology · Albania

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-10
The petitioner proposes to continue her research in molecular biology, specifically focusing on identifying drug targets and their mechanisms of action in complex biological samples. Her work utilizes proteogenomic approaches to elucidate the relationship between genetic mutations and protein functions in breast cancer. This research is intended to enhance the understanding of disease mechanisms and inform the development of targeted therapies for cancer, metabolic disorders, and neurodegenerative conditions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Russia

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-28.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 157 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Russia All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist